Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial

Barrett-Lee, Peter, Casbard, Angela C., Abraham, Jacinta, Hood, Kerenza, Coleman, Robert, Simmonds, Peter, Timmins, Hayley, Wheatley, Duncan, Grieve, Robert, Griffiths, Gareth and Murray, Nick 2014. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial. The Lancet Oncology 15 (1) , pp. 114-122. 10.1016/S1470-2045(13)70539-4

Full text not available from this repository.
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Additional Information: Available online 11 December 2013
Publisher: Elsevier
ISSN: 1470-2045
Funders: Roche
Last Modified: 07 Feb 2019 11:32
URI: http://orca.cf.ac.uk/id/eprint/88035

Citation Data

Cited 66 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item